96 related articles for article (PubMed ID: 11051252)
1. Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of the 5' end of the ER gene.
Navari JR; Roland PY; Keh P; Salvesen HB; Akslen LA; Iversen OE; Das S; Kothari R; Howey S; Phillips B
Clin Cancer Res; 2000 Oct; 6(10):4026-32. PubMed ID: 11051252
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma.
Shiozawa T; Itoh K; Horiuchi A; Konishi I; Fujii S; Nikaido T
Anticancer Res; 2002; 22(1A):139-43. PubMed ID: 12017277
[TBL] [Abstract][Full Text] [Related]
3. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
[TBL] [Abstract][Full Text] [Related]
4. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines.
Woo IS; Park MJ; Choi SW; Kim SJ; Lee MA; Kang JH; Hong YS; Lee KS
Oncol Rep; 2004 Mar; 11(3):617-22. PubMed ID: 14767512
[TBL] [Abstract][Full Text] [Related]
5. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
Archey WB; McEachern KA; Robson M; Offit K; Vaziri SA; Casey G; Borg A; Arrick BA
Oncogene; 2002 Oct; 21(46):7034-41. PubMed ID: 12370825
[TBL] [Abstract][Full Text] [Related]
6. Mapping of ER gene CpG island methylation-specific polymerase chain reaction.
Lapidus RG; Nass SJ; Butash KA; Parl FF; Weitzman SA; Graff JG; Herman JG; Davidson NE
Cancer Res; 1998 Jun; 58(12):2515-9. PubMed ID: 9635570
[TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.
Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R
Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205
[TBL] [Abstract][Full Text] [Related]
8. Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer.
Sasaki M; Kotcherguina L; Dharia A; Fujimoto S; Dahiya R
Cancer Res; 2001 Apr; 61(8):3262-6. PubMed ID: 11309276
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
10. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells.
Penolazzi L; Lambertini E; Giordano S; Sollazzo V; Traina G; del Senno L; Piva R
J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):1-9. PubMed ID: 15261302
[TBL] [Abstract][Full Text] [Related]
11. Potential link between estrogen receptor-alpha gene hypomethylation and uterine fibroid formation.
Asada H; Yamagata Y; Taketani T; Matsuoka A; Tamura H; Hattori N; Ohgane J; Hattori N; Shiota K; Sugino N
Mol Hum Reprod; 2008 Sep; 14(9):539-45. PubMed ID: 18701604
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract][Full Text] [Related]
13. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
14. [Expression of estrogen receptor beta mRNA in endometrial carcinoma and its significance].
Wen H
Zhonghua Fu Chan Ke Za Zhi; 2001 Feb; 36(2):108-10. PubMed ID: 11783346
[TBL] [Abstract][Full Text] [Related]
15. Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression.
Jazaeri AA; Nunes KJ; Dalton MS; Xu M; Shupnik MA; Rice LW
Oncogene; 2001 Oct; 20(47):6965-9. PubMed ID: 11687977
[TBL] [Abstract][Full Text] [Related]
16. Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions.
Rody A; Holtrich U; Solbach C; Kourtis K; von Minckwitz G; Engels K; Kissler S; Gätje R; Karn T; Kaufmann M
Endocr Relat Cancer; 2005 Dec; 12(4):903-16. PubMed ID: 16322330
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.
Yang X; Ferguson AT; Nass SJ; Phillips DL; Butash KA; Wang SM; Herman JG; Davidson NE
Cancer Res; 2000 Dec; 60(24):6890-4. PubMed ID: 11156387
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotides.
Taylor AH; al-Azzawi F; Pringle JH; Bell SC
Anticancer Res; 2002; 22(6C):3993-4003. PubMed ID: 12553024
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
[TBL] [Abstract][Full Text] [Related]
20. CpG island methylation in carcinoid and pancreatic endocrine tumors.
Chan AO; Kim SG; Bedeir A; Issa JP; Hamilton SR; Rashid A
Oncogene; 2003 Feb; 22(6):924-34. PubMed ID: 12584572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
